Brief: Natco Pharma March-Quarter Consol Net Profit 2.68 Billion Rupees
29/05/2026 10:35
BRIEF-Natco Pharma March-Quarter Consol Net Profit 2.68 Billion Rupees May 29 (Reuters) - Natco Pharma Ltd NATP.NS:
NATCO PHARMA MARCH-QUARTER CONSOL NET PROFIT 2.68 BILLION RUPEES
NATCO PHARMA MARCH-QUARTER CONSOL REVENUE FROM OPERATIONS 7.39 BILLION RUPEES
Source text: ID:nBSE8vJ6vT
Further company coverage: NATP.NS
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Natco Pharma
See all newsBrief: Natco Pharma Launches Carboplatin Injection In Us With Teyro Labs
India's Natco Pharma jumps after launching ovarian cancer drug in US
Brief: Natco Pharma Announces Launch Of Carboplatin Injection In The U.S. Market
Brief: Natco Pharma To Increase Its Investment In Egenesis To $16.70 Million
Brief: Natco Pharma Approves Rights Issue Up To 12.79 Billion Rupees